Ireland
--:--IST
Recruiting Not applicable

Effects of Kinesio Taping on Thoracolumbar Fascia Flexibility in Patients With Shoulder Injury

NCT07624136 · tracked via the Priya Life Science Turkey tracker
Sponsor
Kübra Sarıoğlu
Phase
Not applicable
Started
2026-05-20
Last updated
2026-06-03

Condition(s) studied

Subacromial Impingement SyndromeShoulder Pain

Investigational drug(s) / intervention(s)

kinesio taping

kinesio taping: Assessments will be performed immediately before the intervention and 45 minutes after tape application in both groups. Outcome measures will include pain intensity during rest and activity assessed using the Visual Analog Scale (VAS), trunk range of motion measured by goniometry, trunk flexibility assessed by tape measurements, thoracolumbar fascia flexibility evaluated using a goniometric platform, lumbar mobility assessed by the Modified Schober Test, and posterior shoulder capsule tightness. Participants in the intervention group will receive corrective kinesio taping applied in a horn-shaped configuration, whereas the sham group will receive a tension-free tape application from the lateral trunk/axillary region toward the hip without therapeutic fascial correction.

Study summary

The aim of this randomized controlled trial is to investigate the acute effects of fascia correction Kinesio Taping applied to the thoracolumbar fascia (TLF) in individuals with Subacromial Impingement Syndrome (SIS). Participants will be randomly allocated into an intervention group and a sham taping control group. The intervention group will receive fascia correction Kinesio Taping applied to the thoracolumbar region, while the control group will receive sham taping without therapeutic effect. Clinical parameters including pain intensity, trunk range of motion, thoracolumbar fascia flexibility, lumbar mobility, and posterior shoulder capsule tightness will be assessed before the intervention and 45 minutes after the application. This study aims to provide evidence regarding the acute clinical effects of thoracolumbar fascia modulation in individuals with Subacromial Impingement Syndrome.

Eligibility

Sex
ALL
Min age
20 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * age between 20 and 40 years, * Body Mass Index (BMI) within the normal range (20-24.9 kg/m²), * a chronic (symptoms persisting for \>3 months) SIS diagnosis Exclusion Criteria: * any shoulder pathology other than SIS (e.g., rotator cuff tear, glenohumeral joint problems), * inability to perform 90° shoulder flexion due to joint limitation or pain ≥8 on the VAS, * overweight or obesity (BMI \>25 kg/m²), * previous back surgery, * low back pain within the last six months, scoliosis, radiologically diagnosed kyphosis or thoracolumbar disc herniation, sacroiliac joint problems, restricted pelvic range of motion (anterior-posterior pelvic tilt), and scapular dyskinesia.

Primary outcome measure(s)

  • thoracolumbar fascia flexibility — 15 minutes
    The flexibility of the thoracolumbar fascia was evaluated using a goniometric platform. A goniometric platform was placed on a table in front of the participants. Patients were asked to clasp their hands in front at 90° of shoulder flexion, holding a wooden marker between their hands. Patients performed maximum trunk rotation, first to the right and then to the left, while ensuring their arms followed the movement of the trunk. The rotation degree reached by the marker was recorded on the goniometric platform. The test was repeated three times for each direction with one-minute rest intervals, and the average values were recorded. A decrease in rotation range during repeated trials or restricted movement was considered indicative of TLF tightness.

Trial sites (1)

FacilityCityRegionStatus
Hacettepe Sporcu Sağlığı Ünitesi Ankara Altindag Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07624136 on ClinicalTrials.gov ↗ ← All trials in Turkey